Skip to main content
Covid vaccine vials

Medicine's David Canaday researches declining antibody levels in Pfizer vaccine recipients

MEDIA | October 6, 2021
STORY BY: EDITORIAL STAFF

Moderna developing COVID-19-flu combo vaccine; U.S. COVID-19 cases reach 40 million

cleveland.com (subscription required): David Canaday, professor at the School of Medicine, discussed his study showing that antibodies drastically decreased in nursing home residents and caregivers six months after receiving the second dose of the Pfizer vaccine.

EXPLORE MORE:
SCHOOL OF MEDICINE, MEDIA